Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)

The generic Adderall tablets were Teva mfg bottles with Barr stamp tablets the first month since taking over and Adderall is the ADD, and especially adult ADD (and college to middle age) Rx to 'have' these days...and CorePharma (the other generic which does not have the original Shire patent formulation) is smeared all over the net as crap, yet is what WalGreens carries for the generic (at a higher cost too??)...those are the latest facts as of last time I checked -> and check the charts -> a couple days b4 I picked was when TEVA shares really shot up (kicking self for not filling that thing on the original date about a week earlier - the lightbulb that sparked my green thumb) --> right about when the first new TEVA bottles were shipped...put it all together and all I own is that 1) I like generic pharma companies & 2) TEVA has a good existing in-demand product lineup and I see them making wise future acquisitions (such as the Barr / Adderall acquisition)...

cashkid79

massive cash flow, nice FY11 P/E

Excellent managment and number one in all global markets

I believe that Teva will outperform the S&P over the next 2-4 years. With its strong generic business,Teva fills 1 out of every 6 Prescriptions in the U.S, and aggressive ambition to build its Branded business Teva s piosed to be a top performing company. It recent aquistion of Barr, and thier desire to be the leader in Womens Heath, while al others are runnin away from this area, shows Tevas' strong desire to join the big boys like Pfizer and JNJ in becoming a leader in Braded Pharmaceuticals. Teva has built a model with its foundations in generic medicines that allows for the company to have a strong R&D department that is self sufficient in raising capital to brin new products to the market on the branded side as well as aggresively going after new generic business.

Teva produces quality products at affordable prices. I use 2 Teva perscription generic products on a daily basis. Teva is a 100 year old company that has grown from being a Jerusalem pharmacy making its own medicinal compounds to a multinational producer of ethical & generic drugs & with its entry into the bio simmilar market it will continue to prosper. With the ever increasing longevity of people in the developed world the demand for medication is increasing to assure the quality of life in old age. Full Disclosure: I am a long time holder of a small postion in TEVA on the TASE mkt., my only 2 regrets are I did not buy more shares years ago & the Dividend is very small

generics is the future.

Say no more

Can you say Obama!!!!

Teva has a near strangle hold on the generics market, which should help them to aggressively boost revenues over the next 5-10 years.

Analysts are often hesitant b/c Teva's MS drug, Copaxone, may see generic competition from Mylan. I think this is already baked into the stock price. However, I think there will be either two outcomes: (1) Mylan won't be able to bring the drug to market (as Teva claims), or (2) even if they do, Teva should be coming out with an oral version of Copaxone within the next year or two. My mother has MS and I physically give her Copaxone shots, and I see the devastating effects of injections. An oral form of Copaxone would be absolutely huge for Teva and for MS patients in general. I think the market underestimates the upside.

outperform

Teva has great plans for the future: They're always growing and want to double the sales withing the next 5 years.
With the good management and good purchases I believe in its slow but constant growth.

Reliable growth. Not oversold, but underbought.

core stock

great player in genarics

TEVA is constantly buying up hot drug properties and has a vurtual corner on the worldwide generics market, which will continue to see growth as the US struggles to bring down health care costs. Patents awarded on drugs seem to be of shorter duration these days, particulalry abroad where emerging markets are also going to be a significant factor in growth of demand.

WIth ObamaCare coming through, generics will be king.

Just what I think... John is never wrong.

generics, generics

Vacuuming up drugs as they become generic. Growing fast. Has a platoon of lawyers fighting (and winning) approval to get patented meds turn to generic sooner.